S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ZYNE Zynerba Pharmaceuticals Inc

1.30

0.00 (0.00%)

Apr 30 2024 - Closed

Delayed by 15 minutes

Zynerba receives FDA guidance for Phase 3 trial design for Zygel in rare genetic disorder

To read the full story on Seeking Alpha, click here.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Zynerba Pharmaceuticals Charts.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Zynerba Pharmaceuticals Charts.

Zynerba Pharmaceuticals Inc News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Thursday 19 October 2023 (6 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 October 2023 (7 months ago) • Edgar (US Regulatory)

More Zynerba Pharmaceuticals Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

NaturalShrimp (QB)

Mullen Automotive

Atacama Resources (PK)

NioCorp Developments

Fannie Mae (QB)

Branded Legacy (PK)

MicroCloud Hologram

Tonner One World (PK)

International Star (PK)

Virexit Technologies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions